Developing multi-specific aptamers for safe, potent, and long-lasting treatment of geographic atrophy
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2022 · $247,641
Jul 1, 2022 – Jun 30, 2023
Solicitation PA21-259 (2021) · Topic 100
Fully modified bispecific aptamer for effective combination therapy of neovascular ocular diseases
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2022 · $1,499,914
May 1, 2022 – Apr 30, 2024
Solicitation PA18-574 (2018) · Topic NEI
Developing a multivalent agent for long-lasting treatment of diabetic macular edema
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2021 · $224,653
Sep 1, 2021 – Aug 31, 2022
Solicitation PA20-260 (2020) · Topic NEI
Targeting SDF-1 for effective wet AMD treatment
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2020 · $1,716,915
Aug 1, 2020 – Jul 31, 2022
Solicitation PA18-574 (2018) · Topic NEI
Real-Time Small-Volume Blood Sampling and Analysis for Coagulopathy of Trauma Analytes
SBIR Phase II · Department of Defense (Defense Health Agency) · 2020 · $3,049,750
Jul 6, 2020 – Nov 5, 2021
Solicitation 15.1 (2015) · Topic DHP15-012
Fully modified bispecific aptamer for effective combination therapy of neovascular ocular diseases
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2020 · $224,973
Mar 1, 2020 – Feb 28, 2021
Solicitation PA18-574 (2018) · Topic NEI
Targeting PDGFs for Potential Treatment of Proliferative Vitreoretinopathy
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2019 · $224,946
Sep 30, 2019 – Sep 29, 2020
Solicitation PA18-574 (2018) · Topic NEI
Targeting SDF-1 for effective wet AMD treatment
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2019 · $282,661
Sep 30, 2019 – Sep 29, 2020
Solicitation PA18-574 (2018) · Topic NEI
Aptamer-enabled multiplex electrochemical sensor for robust and efficient assessment of flu vaccine potency
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2019 · $222,999
Apr 1, 2019 – Dec 31, 2020
Solicitation PA18-574 (2018) · Topic NIAID
Topical delivery of therapeutic aptamers
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2018 · $293,239
Sep 30, 2018 – Sep 29, 2019
Solicitation PAR17-035 (2017) · Topic NIBIB
Sustained release of next-generation aptamers to treat wet AMD
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2018 · $299,693
Sep 30, 2018 – Sep 29, 2019
Solicitation PA17-302 (2017) · Topic NEI
Point-of-care testing of fibrinogen for early detection and management of trauma coagulopathy
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2018 · $219,883
Sep 1, 2018 – May 31, 2019
Solicitation PA17-302 (2017) · Topic NHLBI
Scalable High Quality Aptamer Generation via Chemically-Augmented Particle Display
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2018 · $1,680,289
Jun 4, 2018 – May 31, 2020
Solicitation PA16-302 (2016) · Topic 300
Targeting SDF for effective wet AMD treatment
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2017 · $250,102
Sep 30, 2017 – Sep 29, 2018
Solicitation PA16-302 (2016) · Topic N
Next generation aptamers for faster safer more sensitive in vivo PET imaging
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2017 · $299,544
Sep 15, 2017 – Jun 30, 2019
Solicitation PA16-302 (2016) · Topic NIBIB
Scalable High Quality Aptamer Generation via Chemically Augmented Particle Display
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2017 · $223,840
Jul 14, 2017 – Jan 13, 2018
Solicitation PA16-302 (2016) · Topic 300
Real-time Point of Care Insulin Monitoring Device for Improved Diabetes Management
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2017 · $1,433,165
Jul 1, 2017 – Jun 30, 2019
Solicitation PA16-302 (2016) · Topic 200
Fully modified bispecific aptamer for effective wet AMD combination treatment
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2017 · $202,821
May 1, 2017 – Apr 30, 2018
Solicitation PA15-269 (2015) · Topic N
Aptamer-Enabled High-sensitivity Troponin assay for rapid POC diagnosis of myocardial infarction
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2016 · $223,148
Sep 1, 2016 – Feb 28, 2019
Solicitation HL14-011 (2014) · Topic NHLBI
Universal Microfluidic Device Platform to Enable Real-Time Continuous Measurement of Biomarkers of Coagulopathy Directly in Trauma Victims
SBIR Phase I · Department of Defense (Defense Health Agency) · 2015 · $150,000
Sep 22, 2015 – Apr 29, 2016
Solicitation 2015.1 (2015) · Topic DHP15-012
Real-time Continuous Intravenous Drug Monitor for Closed-Loop Anesthesia Delivery
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2015 · $220,310
Aug 5, 2015 – Feb 4, 2017
Solicitation PA14-071 (2015) · Topic 300
Particle display: a new paradigm in high throughput discovery of ultra-high perfo
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2015 · $1,498,000
Dec 5, 2014 – Nov 30, 2017
Solicitation PA13-088 (2014) · Topic 300
Real-time Point of Care Insulin Monitoring Device for Improved Diabetes Managemen
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2014 · $248,839
Sep 23, 2014 – Aug 31, 2016
Solicitation PA13-088 (2014) · Topic 200
Particle display: a new paradigm in high throughput discovery of ultra-high perfo
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2014 · $224,700
Solicitation PA13-088 (2014) · Topic NIGMS · Research partner: Stub
